Adenosine as a potential analgesic target in inflammatory and neuropathic pains

CNS Drugs

Volumn 13, Issue 2, 2000, Pages 77-85

  Dickenson, Anthony H ^a   Suzuki, Rie ^a   Reeve, Alison J ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; ADENOSINE; ADENOSINE A1 RECEPTOR; ADENOSINE A2 RECEPTOR; ADENOSINE DERIVATIVE; HISTAMINE; SEROTONIN;

ANALGESIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTINOCICEPTION; ARTICLE; HUMAN; MOTOR DYSFUNCTION; NEUROMODULATION; NEUROPATHY; NOCICEPTION; NONHUMAN; NUCLEOTIDE METABOLISM; PRIORITY JOURNAL; SUBSTANTIA GELATINOSA;

EID: 0034006941     PISSN: 11727047     EISSN: None     Source Type: Journal    
DOI: 10.2165/00023210-200013020-00001     Document Type: Article

References (107)

1. Dickenson AH. Mechanisms of the analgesic actions of opiates and opioids. Br Med Bull 1991; 47: 690-702
2. Dickenson AH. Where and how do opioids act? In: Gebhart GF, Hammond DL, Jenson TS, editors. Proceedings of the 7th World Congress on Pain. Progress in Pain Research and Management. Vol. 2. Seattle (WA): IASP Press, 1994: 525-52
3. Yaksh TL. The spinal actions of opioids. In: Herz A, editor. Handbook of experimental pharmacology. Opioids. Vol. 104/11. Heidelberg: Springer-Verlag, 1993; 53-90
4. Yaksh TL, Rudy TA. Studies on the direct spinal action of narcotics in the production of analgesia in the rat. J Pharmacol Exp Ther 1977; 202: 411-28
5. Fredholm BB, Abbracchio MP, Burnstock G, et al. Nomenclature and classification of purinoreceptors. Pharmacol Rev 1994; 46 (2): 143-56
6. Ralevic V, Burnstock G. Receptors for purines and pyramidines. Pharmacol Rev 1998; 50: 413-92
7. 2 receptors of the substantia gelatinosa are located predominantly on intrinsic neurons: an autoradiography study. J Pharmacol Exp Ther 1988; 247: 757-64
8. 1 receptors in the human brain: a quantitative autoradiographic study. Neuroscience 1987; 22: 827-39
9. Goodman RR, Kuhar MJ, Hester L, et al. Adenosine receptors: autoradiographic evidence for their location on axon terminals of excitatory neurones. Science 1983; 220: 967-9
10. Goodman RR, Snyder SH. Autoradiographic localization of adenosine receptors in rat brain using [3H]cyclohexyladenosine. J Neurosci 1982; 2: 1230-41
11. Geiger JD, LaBella FS, Nagy JI. Characterization and localization of adenosine receptors in rat spinal cord. J Neurosci 1984; 4: 2303-10
12. Linden J. Cloned adenosine A3 receptors: pharmacological properties, species differences and receptor functions. Trends Pharmacol Sci 1994; 15: 298-306
13. Murphy S, Pearce B. Functional receptors for neurotransmitters on astroglial cells. Neuroscience 1987; 22: 381-94
14. Sweeney MI, White TD, Sawynok J. Morphine-evoked release of adenosine from the spinal cord occurs via a nucleoside carrier with differential sensitivity to dipyridamole and nitrobenzylthioinosine. Brain Res 1993; 614: 301-7
15. Braas KM, Newby AC, Wilson VS, et al. Adenosine-containing neurones in the brain localized by immunocytochemistry. J Neurosci 1986; 6: 1952-61
16. Garthwaite J, Garthwaite G, Palmer RMJ, et al. NMDA receptor activation induces nitric oxide synthesis from arginine in rat brain slices. Eur J Pharmacol 1989; 172: 413-6
17. 1 receptors mediate the presynaptic inhibition of calcitonin gene related peptide release by adenosine in the rat spinal cord. Eur J Pharm 1993; 231: 139-42
18. Geiger JD, Nagy JI. Distribution of adenosine deaminase activity in rat brain and spinal cord. J Neurosci 1986; 6: 2707-14
19. Nagy JI, Daddona PE. Anatomical and cytochemical relationships of adenosine deaminase-containing primary afferent neurons in the rat. Neurosci Int 1985, 15: 799-813
20. Nagy JI, Buss M, LaBella LA, et al. Immunohistochemical localization of adenosine deaminase in primary afferent neurons of the rat. Neurosci Lett 1984; 48: 133-8
21. Geiger JD, Nagy JI. Heterogeneous distribution of adenosine transport sites labelled by [3H]nitrobenzylthioinosine in rat brain: an autoradiographic and membrane binding study. Brain Res Bull 1984; 13: 657-66
22. Geiger JD, Nagy JI. Localization of [3H]nitrobenzylthioinosine binding sites in rat spinal cord and primary afferent neurones. Brain Res 1985; 347: 321-7
23. Sawynok J, Sweeney MI. The role of purines in nociception. Neuroscience 1989; 32: 557-69
24. Ahlijanian MK, Takemori AE. Effects of (-)-N6-(R-phenylisopropyl)-adenosine (PIA) and caffeine on nociception and morphine-induced analgesia, tolerance and dependence in mice. Eur J Pharmacol 1985; 112: 171-9
25. Holmgren M, Hedner J, Nordberg G, et al. Antinociceptive effects in the rat of an adenosine analogue, N6-phenylisopropyladenosine. J Pharm Pharmacol 1983; 35: 679-80
26. Holmgren M, Hedner J, Mellstrand T, et al. Characterization of the antinociceptive effects of some adenosine analogues in the rat. Naunyn Schmiedebergs Arch Pharmakol 1986; 334: 290-3
27. Vapaatalo H, Onken D, Neuvonen PJ, et al. Stereospecificity in some central and circulatory effects of phenylisopropyl-adenosine (PIA). Arzneimittl-Forsch 1975; 25: 407-10
28. Herrick-Davis K, Chippari S, Luttinger D, et al. Evaluation of adenosine agonists as potential analgesics. Eur J Pharmacol 1989; 162: 365-9
29. DeLander GE, Hopkins CJ. Spinal adenosine modulates descending antinociceptive pathways stimulated by morphine. J Pharm Exp Ther 1986; 239: 88-93
30. Doi T, Kuzuna S, Maki Y. Spinal antinociceptive effects of adenosine compounds in mice. Eur J Pharmacol 1987; 137: 227-31
31. Karlsten R, Gordh Jr T, Hartvig P, et al. Effects of intrathecal injection of the adenosine receptor agonists R-phenylisopropyl-adenosine and N-ethylcarboxamide-adenosine on nociception and motor function in the rat. Anesth Analg 1990; 71: 60-4
32. Malmberg AB, Yaksh TL. Pharmacology of the spinal action of ketorolac, morphine, ST-91, U50488H, and L-PIA on the formalin test and isobolographic analysis of the NSAID interaction. Anesthesiology 1993; 79: 270-81
33. Post C. Antinociceptive effects in mice after intrathecal injection of 5′-N-Ethylcarboxamide adenosine. Neurosci Lett 1984; 51: 325-30
34. Sawynok J, Sweeney MI, White TD. Classification of adenosine receptors mediating antinociception in the rat spinal cord. Br J Pharmacol 1986; 88: 923-30
35. Sosnowski M, Yaksh TL. Role of spinal adenosine receptors in modulating the hyperesthesia produced by spinal glycine receptor antagonism. Anesth Analg 1989; 69: 587-92
36. Yarbrough GY, McGuffin-Clineschmidt JC. In vivo behavioral assessment of central nervous system purinergic receptors. Eur J Pharmacol 1981; 76: 137-44
37. Reeve AJ, Dickenson AH. Electrophysiological study on spinal antinociceptive interactions between adenosine and morphine in the dorsal horn of the rat. Neurosci Lett 1995; 194: 81-4
38. Reeve AJ, Dickenson AH. The roles of spinal adenosine receptors in the control of acute and more persistent nociceptive responses of dorsal horn neurones in the anaesthetized rat. Br J Pharmacol 1995; 116: 2221-8
39. 1-receptor agonist, morphine, and an NMDA-receptor antagonist, J Neurophys 1998; 79: 1494-507
40. Mendell LM. Physiological properties of unmyelinated fiber projection to the spinal cord. Exp Neurol 1966; 16: 316-32
41. Davies SN, Lodge D. Evidence for involvement of N-methyl-D-aspartate receptors in wind-up of class 2 neurones in the dorsal horn of the rat. Brain Res 1987; 424: 402-6
42. Dickenson AH, Sullivan AF. Evidence, for a role of the NMDA receptor in the frequency dependent potentiation of deep rat dorsal horn nociceptive neurones following C-fibre stimulation. Neuropharmacol 1987; 26: 1235-8
43. White TD. Potentiation of excitatory amino-acid-evoked adenosine release from rat cortex by inhibitors of adenosine kinase and adenosine deaminase and by acadesine. Eur J Pharmacol 1996; 303: 27-38
44. Dora CD, Koch S, Sanchez A, et al. Intraspinal injection of adenosine agonists protect against L-NAME induced neuronal loss in the rat. J Neurotrauma 1998; 15: 473-83
45. Keil GJH, DeLander GE. Altered sensory behaviors in mice following manipulation of endogenous spinal adenosine neurotransmission. Eur J Pharmacol 1996; 312: 7-14
46. Backonja M, Arndt G, Gombar KA, et al. Response of chronic neuropathic pain syndromes to ketamine: a preliminary study. Pain 1994; 56: 51-7
47. Chapman V, Dickenson AH. Enhanced responses of rat dorsal horn neurones after UV irradiation of the hindpaw; roles of the NMDA receptor. Neurosci Lett 1994; 176: 41-4
48. Dickenson AH. NMDA receptor antagonists as analgesics. In: Fields HL, Liebeskind JC, editors. Pharmacological approaches to the treatment of chronic pain: new concepts and critical issues. Progress in pain research and management. Vol. I. Seattle (WA): IASP Press, 1994: 173-87
49. Eide PK, Jorum E, Stubhaug A, et al. Relief of post-herpetic neuralgia with the N-methyl-D-aspartic acid receptor antagonist ketamine: a double-blind, cross-over comparison with morphine and placebo. Pain 1994; 58: 347-54
50. Ma Q-P, Woolf CJ. Noxious stimuli induce an N-methyl-D-aspartate receptor-dependent hypersensitivity of the flexion withdrawal reflex to touch: implications for the treatment of mechanical allodynia. Pain 1995; 61: 383-90
51. Persson J, Axelsson G, Hallin RG, et al. Beneficial effects of ketamine in a chronic pain state with allodynia, possibly due to central sensitization. Pain 1995; 60: 217-22
52. Sherman SE, Loomis CW. Morphine insensitive allodynia is produced by intrathecal strychnine in the lightly anesthetized rat. Pain 1994; 56: 17-29
53. Yaksh TL. Behavioral and autonomic correlates of the tactile evoked allodynia produced by spinal glycine inhibition: effects of modulatory receptor systems and excitatory amino acid antagonists. Pain 1989; 37: 111-23
54. Desmeules JA, Kayser V, Guilbaud G. Selective opioid receptor agonists modulate mechanical allodynia in an animal model of neuropathic pain. Pain 1993; 53: 277-85
55. Jadad AR, Carroll D, Glynn CJ, et al. Morphine responsiveness of chronic pain: double-blind randomized crossover study with patient-controlled analgesia. Lancet 1992; 339: 1367-71
56. Sollevi A. Adenosine for pain control. Acta Anaesthesiol Scand 1997; Suppl. 110: 135-6
57. Segerdahl M, Ekblom A, Sollevi A. The influence of adenosine, ketamine, and morphine on experimentally induced ischemic pain in healthy volunteers. Anesth Analg 1994; 79: 787-91
58. Segerdahl M, Ekblom A, Sjolund K-F, et al. Systemic adenosine attenuates touch evoked allodynia induced by mustard oil in humans. Neuroreport 1995; 6: 753-6
59. Ekblom A, Segerdahl M, Sollevi A. Adenosine increases the cutaneous heat pain threshold in healthy volunteers. Acta Anaesthesiol Scand 1995; 39: 717-22
60. Rane K, Segerdahl M, Goiny M, et al. Intrathecal adenosine administration: a phase I clinical safety study in healthy volunteers, with additional evaluation of its influence on sensory thresholds and experimental pain. Anesthesiology 1998; 89: 1108-15
61. Kingery WS. A critical review of controlled clinical trials for peripheral neuropathic pain and complex regional syndrome. Pain 1997; 73: 123-39
62. Guieu R, Peragut JC, Roussel P, et al. Adenosine and neuropathic pain. Pain 1996; 68: 271-4
63. Sugimoto T, Bennett GJ, Kajander KC. Transsynaptic degeneration in the superficial dorsal horn after sciatic nerve injury: effects of chronic constriction injury, transection, and strychnine. Pain 1990; 42: 205-13
64. 1 receptor agonist R-phenylisopropyl adenosine reduces presumed pain behaviour in a rat model of central pain. Neurosci Lett 1998; 243: 89-92
65. Cui J-G, Sollevi A, Linderoth B, et al. Adenosine receptor activation suppresses tactile hypersensitivity and potentiates spinal cord stimulation in mononeuropathic rats. Neurosci Lett 1997; 223: 173-6
66. Lee Y-W, Yaksh TL. Pharmacology of the spinal adenosine receptor which mediates the antiallodynic action of intrathecal adenosine agonists. J Pharmacol Exp Ther 1996; 277: 1642-8
67. Sjolund KF, Sollevi A, Segerdahl M, et al. Intrathecal and systemic R-phenylisopropyl-adenosine reduces scratching behaviour in a rat mononeuropathy model. Neuroreport 1996; 7: 1856-60
68. Kim SH, Chung JM. An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain 1992; 50: 355-63
69. Lavand'homme PM, Eisenach JC. Exogenous and endogenous adenosine enhance the spinal antiallodynic effects of morphine in a rat model of neuropathic pain. Pain 1999; 80: 31-6
70. Belfrage M, Sollevi A, Segerdahl M, et al. Systemic adenosine infusion alleviates spontaneous and stimulus evoked pain in patients with peripheral neuropathic pain. Anesth Analg 1995; 81: 713-7
71. Sollevi A, Belfrage, Lundeberg T, et al. Systemic adenosine infusion: a new treatment modality to alleviate neuropathic pain. Pain 1995; 61: 155-8
72. 1-selective adenosine agonist abolishes allodynia elicited by vibration and touch after intrathecal injection. Anesth Analg 1995; 80: 844-7
73. Sollevi A, Rane K, Segerdahl M, et al. Intrathecal adenosine injection elevates cutaneous pain thresholds in man [abstract]. In: 8th World Congress on Pain: 1996 Aug 18-22: Vancouver. Seattle (WA): IASP Press, 1996: 356
74. Dolphin AC, Prestwich SA. Pertussis toxin reverses adenosine inhibition of neuronal glutamate release. Nature 1985; 316: 148-50
75. Craig CG, White TD. Low-level N-methyl-D-aspartate receptor activation provides a purinergic inhibitory threshold against further N-methyl-D-aspartate-mediated neurotransmission in the cortex. J Pharm Exp Ther 1992; 260: 1278-84
76. Craig CG, White TD. N-methyl-D-aspartate and non-N-methyl-D-aspartate-evoked adenosine release from rat cortical slices: distinct purinergic sources and mechanisms of release. J Neurochem 1993; 60: 1073-80
77. Conway CM, Marsala M, Somogyi GT, et al. Intrathecal NMDA-induced release of spinal adenosine and amino acids. Soc Neurosci Abstr 1997; 23: 1013
78. Mao J, Price DD, Mayer DJ, et al. Intrathecal MK-801 and local nerve anesthesia synergistically reduce nociceptive behaviors in rats with experimental peripheral mononeuropathy. Brain Res 1992; 576: 254-62
79. Qian J, Brown SD, Carlton SM. Systemic ketamine attenuates nociceptive behaviors in a rat model of peripheral neuropathy. Brain Res 1996; 715: 51-62
80. Sumida T, Smith MA, Machara Y, et al. Spinal R-phenyl-isopropyl adenosine inhibits spinal dorsal horn neurons responding to noxious heat stimulation in the absence and presence of sensitization. Pain 1998; 74: 307-13
81. Sawynok J. Purines in pain management. Curr Opin CPNS Invest Drugs 1999; 1: 27-38
82. 1 receptor-mediated excitation of nociceptive afferents innervating the normal and arthritic knee joint. Br J Pharm 1998; 125: 1267-71
83. Sawynok J, Zarrindast MR, Reid AR, et al. Adenosine A3 receptor activation produces nociceptive behaviour and edema by release of histamine and 5-hydroxytryptamine. Eur J Pharmacol 1997; 333: 1-7
84. Sawynok J. Adenosine receptor activation and nociception. Eur J Pharmacol 1998; 347: 1-11
85. Abbott FV, Melzack R, Samuel C. Morphine analgesia in the tail-flick and formalin pain tests is mediated by different neural systems. Exp Neurol 1982; 75: 644-51
86. Dubuisson D, Dennis SG. The formalin test: a quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats. Pain 1977; 4: 161-74
87. Hargreaves K, Dubner R, Brown F, et al. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 1988; 32: 77-88
88. Tjolsen A, Berge O-G, Hunskaar S, et al. The formalin test: an evaluation of the method. Pain 1992; 51: 5-17
89. Wheeler-Aceto H, Cowan A. Standardization of the rat paw formalin test for the evaluation of analgesics. Psychopharmacol 1991; 104: 35-44
90. Doak GJ, Sawynok J. Complex role of peripheral adenosine in the genesis of the response to subcutaneous formalin in the rat. Bur J Pharmacol 1995; 281: 311-8
91. Karlsten R, Gordh T, Post C. Local antinociceptive and hyperalgesic effects in the formalin test after peripheral administration of adenosine analogues in mice. Pharmacol Toxicol 1992; 70: 434-8
92. Holton FA, Holton P. The capillary dilator substances in dry powders of spinal roots: a possible role of adenosine triphosphate in chemical transmission from nerve endings. J Physiol 1954; 126: 124-40
93. Holton P. The liberation of adenosine triphosphate on antidromic stimulation of sensory nerves. J Physiol 1959; 145: 494-504
94. Rae CP, Mansfield MD, Dryden C, et al. Analgesic effect of adenosine on ischaemic pain in human volunteers. Br J Anaesth 1999; 82: 427-8
95. Sjolund KF, Segerdahl M, Sollevi A. Adenosine reduces secondary hyperalgesia in two human models of cutaneous inflammatory pain. Anesth Analg 1999; 88: 605-10
96. Bleehen T, Keele CA. Observations on the allogenic actions of adenosine compounds on the human blister base preparation. Pain 1977; 3: 367-77
97. Poon A, Sawynok J. Antinociception by adenosine analogs and an adenosine kinase inhibitor: dependence on formalin concentration. Eur J Pharmacol 1995; 286: 177-84
98. Sawynok J, Reid A, Poon A. Peripheral antinociceptive effect of an adenosine kinase inhibitor, with augmentation by an adenosine deaminase inhibitor, in the rat formalin test. Pain 1998; 74: 75-81
99. Keil 2nd GJ, DeLander GE. Spinally-mediated antinociception is induced in mice by an adenosine kinase-, but not by an adenosine deaminase-, inhibitor. Life Sci 1992; 51: 171-6
100. Keil 2nd GJ, DeLander GE. Adenosine kinase and adenosine deaminase inhibition modulate spinal adenosine- and opioid agonist-induced antinociception in mice. Eur J Pharmacol 1994; 271: 37-46
101. Poon A, Sawynok J. Antinociception by adenosine analogues and inhibition of adenosine metabolism in an inflammatory thermal hyperalgesia model in the rat. Pain 1998; 74: 235-45
102. Meghji P. Adenosine production and metabolism. In: Stone TW, editor. Adenosine in the nervous system. London: Academic Press, 1991: 25-42
103. Dickenson AH, Sullivan AF. Combined therapy in analgesia; seeking synergy. Curr Opin Anaesthesiol 1993; 6: 861-5
104. 2 adenosine receptors in spinal mechanisms of antinociception. Eur J Pharm 1987; 139: 215-23
105. Segerdahl M, Forsberg C, Sollevi A. Ketamine and adenosine infusion prevent thermal changes in the secondary hyperalgesic area after mustard oil skin application [abstract]. In: 8th World Congress on Pain: 1996 Aug 18-22: Vancouver. Seattle (WA): IASP Press, 1996: 35
106. Sollevi A. Adenosine infusion during isoflurane-nitrous oxide anaesthesia: indications of perioperative analgesic effect. Acta Anaesthesiol Scand 1992, 36: 595-9
107. Sylven C, Eriksson B, Jensen J, et al. Analgesic effects of adenosine during exercise-provoked myocardial ischaemia. Neuroreport 1996; 7: 1521-5